Table 1:
All patients (N = 119) | |
---|---|
Time from hospital admission to anakinra initiation, mean (SD) days | 7.3 (6.1) |
Gender, n (%) | |
Female | 43 (36.1) |
Male | 76 (63.9) |
Age, mean (SD) years | 64.7 (12.5) |
Ethnicity, n (%) | |
Black | 36 (48.6) |
Hispanic | 19 (25.7) |
White | 14 (18.9) |
Mixed | 5 (6.8) |
Missing | 45 (37.8) |
CCI score, mean (SD) | 4.7 (3.9) |
CCI score, categorical n (%) | |
0 | 15 (12.6) |
1 | 21 (17.6) |
2 | 10 (8.4) |
≥3 | 73 (61.3) |
Area of location, n (%) | |
Rural | 0 (0.0) |
Urban | 119 (100) |
Hospital size, n (%) | |
<500 beds | 5 (4.2) |
≥500 beds | 114 (95.8) |
Number of comorbidities,an (%) | |
0 | 5 (4.2) |
1 | 12 (10.1) |
2 | 25 (21.0) |
3 | 27 (22.7) |
4 | 32 (26.9) |
5 | 15 (12.6) |
6 | 3 (2.5) |
Type of comorbidity,bn (%) | |
Hypertension | 92 (77.3) |
Diabetes | 65 (54.6) |
Pulmonary diseases | 59 (49.6) |
Renal conditions | 49 (41.2) |
Obesity | 36 (30.3) |
Congestive heart failure | 35 (29.4) |
MI | 17 (14.3) |
COPD | 17 (14.3) |
Liver disease | 10 (8.4) |
Cerebrovascular disease | 9 (7.6) |
Peripheral vascular disease | 6 (5.0) |
Rheumatologic autoimmune conditions | 1 (0.8) |
CCI, Charlson comorbidity index; COPD, chronic obstructive pulmonary disease; MI, myocardial infarction.
Comorbidities included diabetes, hypertension, pulmonary diseases, heart disease (any of MI, congestive heart failure, peripheral vascular disease, cerebrovascular disease), renal diseases, liver diseases, and obesity.
Patients could be included in more than one group.